The Use of Antidepressants, Anxiolytics, and Hypnotics in People with Type 2 Diabetes and Patterns Associated with Use: The Hoorn Diabetes Care System Cohort
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Objective. With depression being present in approximately 20% of people with type 2 diabetes mellitus (T2DM), we expect equally frequent prescription of antidepressants, anxiolytics, and hypnotics. Nevertheless, prescription data in people with T2DM is missing and the effect of depression on glycaemic control is contradictory. The aim of this study was to assess the prevalence of antidepressants, anxiolytics, and/or hypnotics use in a large, managed, primary care system cohort of people with T2DM and to determine the sociodemographic characteristics, comorbidities, T2DM medication, and metabolic control associated with its use. Method. The prevalence of antidepressants, anxiolytics, and/or hypnotics use in the years 2007–2012 was assessed in the Hoorn Diabetes Care System Cohort from the Netherlands. Results. From the 7016 people with T2DM, 500 people (7.1%) used antidepressants only, 456 people (6.5%) used anxiolytics and/or hypnotics only, and 254 people (3.6%) used a combination. Conclusion. We conclude that in our managed, primary care system 17% of all people with T2DM used antidepressants, anxiolytics, and/or hypnotics. Users of antidepressants, anxiolytics, and/or hypnotics were more often female, non-Caucasian, lower educated, and more often treated with insulin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Depression and Type 2 Diabetes Over the Lifespan
Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008) · Diabetes Care · doi:10.2337/dc08-0985 · Cited by 1,558
Epidemiology of depression and diabetes: a systematic review
Roy, T., & Lloyd, C. E. (2012) · Journal of Affective Disorders · doi:10.1016/s0165-0327(12)70004-6 · Cited by 1,229 · cited 2×
“[13, 14], we expect equally frequent prescription of antidepressants, anxiolytics, and hypnotics.”
for the European Depression in Diabetes (EDID) Research Consortium, Nouwen, A., Winkley, K., Twisk, J., Lloyd, C. E., Peyrot, M., Ismail, K., & Pouwer, F. (2010) · Diabetologia · doi:10.1007/s00125-010-1874-x · Cited by 756 · cited 2×
“Similar reciprocal associations have been observed for anxiety, sleep disorders, and T2DM [4, 5].”
National Patterns in Antidepressant Medication Treatment
Olfson, M., & Marcus, S. C. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.81 · Cited by 730 · cited 2×
“However, studies on the effect of depression/pharmacotherapy on glycaemic control have been contradictory [8–10].”
InfluentialHypnotics' association with mortality or cancer: a matched cohort study
Kripke, D. F., Langer, R. D., & Kline, L. E. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-000850 · Cited by 408
Hermanns, N., Kulzer, B., Krichbaum, M., Kubiak, T., & Haak, T. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01414.x · Cited by 170 · cited 2×
“This is in accordance with other literatures on the association between depression and T2DM [27] in that it may reflect disease progression.”
Wolf, N. J., & Hopko, D. R. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.04.004 · Cited by 116 · cited 1×
“Depression, anxiety, and/or sleep problems are diagnosed using the Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) [6] and are treated with psychotherapy or pharmacotherapy when the patient is unresponsive to the former [7].”
Maintenance use of antidepressants in Dutch general practice: non-guideline concordant
Piek, E., Kollen, B. J., van der Meer, K., Penninx, B. W. J. H., & Nolen, W. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097463 · Cited by 24 · cited 1×
“In concordance with studies from the literature in the general population, we observed that people with T2DM using antidepressants, anxiolytics, and/or hypnotics were more often female, older, non-Caucasian, and having a lower level of education, compared to nonusers [11, 12, 21].”
Cited by
Schipper, S. B. J., Van Veen, M. M., Elders, P. J. M., van Straten, A., Van Der Werf, Y. D., Knutson, K. L., & Rutters, F. (2021) · Diabetologia · doi:10.1007/s00125-021-05541-0 · Cited by 202
Self-citationConnecting insufficient sleep and insomnia with metabolic dysfunction
Duan, D., Kim, L. J., Jun, J. C., & Polotsky, V. Y. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14926 · Cited by 110
Aiding sleep in type 2 diabetes: therapeutic considerations
Tan, X., van Egmond, L., Chapman, C. D., Cedernaes, J., & Benedict, C. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30233-4 · Cited by 72
Rohde, C., Schmitz, N., Thomsen, R. W., & Østergaard, S. D. (2021) · Acta Neuropsychiatrica · doi:10.1017/neu.2020.39 · Cited by 7
Metadata
- Authors
- Mast, R., Rauh, S. P., Groeneveld, L., Koopman, A. D., Beulens, J. W. J., Jansen, A. P. D., Bremmer, M., van der Heijden, A. A. W. A., Elders, P. J., Dekker, J. M., Nijpels, G., Hugtenburg, J. G., & Rutters, F.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2017
- Volume
- 2017
- Pages
- 1-8
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2579934541
- Cited by
- 13
- References
- 8
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.